Sana Biotechnology SANA Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's deferred tax assets and other non-current assets?
- Sana Biotechnology (SANA) reported deferred tax assets and other non-current assets of $563K in Q1 2026.
- How has Sana Biotechnology's deferred tax assets and other non-current assets changed year-over-year?
- Sana Biotechnology's deferred tax assets and other non-current assets decreased by 87.2% year-over-year, from $4.39M to $563K.
- What is the long-term trend for Sana Biotechnology's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Sana Biotechnology's deferred tax assets and other non-current assets has grown at a 75.6% compound annual growth rate (CAGR), from $190K to $3.17M.